Orthofix Medical Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $833.2M+4.2% YoYTTM through 30 Jun 2026
Net Income -$61.7MTTM through 30 Jun 2026
Free Cash Flow -$27.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 68.8% |
| EBITDA Margin | 1.6% |
| Operating Margin | -9.9% |
| Net Margin | -7.4% |
Returns
-20.5%ROE
-10.8%ROA
Balance Sheet Health
Debt / Equity0.35x
Current Ratio2.45x
Net Debt$75.4M
Cash & Equivalents$103.8M
Quality Metrics
Altman Z-Score1.05
Piotroski F-Score5 / 9
FCF Margin-3.3%
Rule of 40-2.1
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $822.3M
Diluted EPS-$1.52TTMFY2025: $-2.33
Dividend
No dividend
Capital Allocation
R&D Spend$61.4M
Capex Intensity5.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Global Spine | $687.7M | +1.8% | |
| Global Limb Reconstruction | $134.7M | +8.4% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.